Latest News

February 05, 2014
CVS Caremark, the nation’s largest pharmacy health care company, and UCSF's Steven Schroeder say selling tobacco products is “clearly antithetical” to the role of pharmacies.
August 27, 2013
UCSF will require everyone who works and studies at UCSF, including faculty, staff, students, trainees, contractors and volunteers, to be tobacco-free.
August 21, 2013
Patients who participated in a smoking-cessation program during hospitalization for mental illness were able to quit smoking and were less likely to be hospitalized again for their psychiatric conditions.
February 12, 2013
The UCSF School of Pharmacy has partnered with Safeway Inc. to help Safeway customers quit smoking, by connecting them with specially trained pharmacists to learn about smoking-cessation programs and other resources.
September 27, 2012
Top box office films last year showed more onscreen smoking than the prior year, reversing five years of steady progress in reducing tobacco imagery in movies, according to a new UCSF study.
July 27, 2012
Suzanne Harris was a registered nurse, worked on a cancer unit and was a mother to a young child when she smoked. Today, she directs the UCSF Fontana Tobacco Treatment Center, which offers comprehensive smoking cessation classes and relapse prevention support.
July 27, 2012
The brains of adolescents who smoke as little as two cigarettes a day respond to images of smoking as do the brains of heavily addicted adult smokers: with pleasure.
May 31, 2012
African-American and Latino children whose mothers smoked during pregnancy are more likely to suffer from acute asthma symptoms in their teens than asthma sufferers whose mothers did not smoke, according to a new study led by a research team at UCSF.
May 25, 2012
The UCSF community is invited to participate in World No Tobacco Day on May 31.
May 03, 2012
A popular smoking cessation medication has been under a cloud of suspicion ever since the Canadian Medical Association Journal published a study in July 2011 reporting “risk of serious adverse cardiovascular events associated with varenicline.” UCSF researchers, however, question the way the previous study was conducted, and their new analysis, scheduled to be published May 4 in BMJ, reaches a very different conclusion.

Pages